Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check6 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the history section.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 added; earlier notices about government funding status and the v3.4.1 revision were removed.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and NIH operations, and updated the record to Revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedUI improvements on the Record History page add a glossary display option and color-coded highlights for changes (green for additions, red for deletions). The page also updates revision notes to v3.4.0, replacing the previous v3.3.4.SummaryDifference1%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the record history, reflecting routine page maintenance with no changes to trial content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.3.3 now appears in the page footer, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.